메뉴 건너뛰기
Movement Disorders
Volumn 26, Issue 3, 2011, Pages 558-559
Serum vitamin B12 and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion
Author keywords

[No Author keywords available]
Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMINO ACID DERIVATIVE; ASPARTATE AMINOTRANSFERASE; CATECHOL METHYLTRANSFERASE; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; IBANDRONIC ACID; LEVODOPA; PREGABALIN; S ADENOSYLHOMOCYSTEINE;
EID: 79953287067     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23419     Document Type: Letter
Times cited : (26)
References (7)
  • 1
    • 71849085542 scopus 로고    scopus 로고
    • Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy
    • Manca D, Cossu G, Murgia D, et al. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy. Mov Disord 2009; 24: 2293-2294.
    • (2009) Mov Disord , vol.24 , pp. 2293-2294
    • Manca, D.1    Cossu, G.2    Murgia, D.3
  • 2
    • 34447545480 scopus 로고    scopus 로고
    • Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome
    • Antonini A, Isaias IU, Canesi M, et al. Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 2007; 22: 1145-1149.
    • (2007) Mov Disord , vol.22 , pp. 1145-1149
    • Antonini, A.1    Isaias, I.U.2    Canesi, M.3
  • 3
    • 71849119462 scopus 로고    scopus 로고
    • Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-dopa gel treatment
    • S236.
    • Onofrj M, Bonanni L, Cossu G, Manca D, Stocchi F, Thomas A. Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-dopa gel treatment. Parkinsonism Relat Disord 2009; 15( Suppl 3):S233-S236.
    • (2009) Parkinsonism Relat Disord , vol.15 , Issue.SUPPL. 3
    • Onofrj, M.1    Bonanni, L.2    Cossu, G.3    Manca, D.4    Stocchi, F.5    Thomas, A.6
  • 4
    • 4644368806 scopus 로고    scopus 로고
    • Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?
    • Postuma RB, Lang AE. Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology 2004; 63: 886-891.
    • (2004) Neurology , vol.63 , pp. 886-891
    • Postuma, R.B.1    Lang, A.E.2
  • 5
    • 0037426415 scopus 로고    scopus 로고
    • Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status
    • Miller JW, Selhub J, Nadeau MR, Thomas CA, Feldman RG, Wolf PA. Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status. Neurology 2003; 60: 1125-1129.
    • (2003) Neurology , vol.60 , pp. 1125-1129
    • Miller, J.W.1    Selhub, J.2    Nadeau, M.R.3    Thomas, C.A.4    Feldman, R.G.5    Wolf, P.A.6
  • 6
    • 57049093277 scopus 로고    scopus 로고
    • Neuropathy as a potential complication of levodopa use in Parkinson's disease
    • Toth C, Brown MS, Furtado S, Suchowersky O, Zochodne D. Neuropathy as a potential complication of levodopa use in Parkinson's disease. Mov Disord 2008; 23: 1850-1859.
    • (2008) Mov Disord , vol.23 , pp. 1850-1859
    • Toth, C.1    Brown, M.S.2    Furtado, S.3    Suchowersky, O.4    Zochodne, D.5
  • 7
    • 2442623636 scopus 로고    scopus 로고
    • Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration
    • Müller T, Renger K, Kuhn W. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Arch Neurol 2004; 61: 657-660.
    • (2004) Arch Neurol , vol.61 , pp. 657-660
    • Müller, T.1    Renger, K.2    Kuhn, W.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.